The primary outcome (a composite of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for unstable angina) occurred in 839 patients in the sitagliptin group (11.4%) and 851 patients in the placebo group (11.6%), which was not significantly different
Manufacturing process of reduced glutathione or the sodium salt thereof according to claims 1 to 6, which comprises: a) production of glutathione from a microbial biomass, preferably a yeast, b) optionally, lysis of said biomass under acidic conditions, c) separation of the biomass and the fragments thereof from the glutathione- containing aqueous solution, d) purification of the aqueous solution of glutathione by resin chromatography, in one or more steps, under controlled temperature and pH conditions, using aqueous eluents only, e) optionally, decolourisation of the aqueous solution of glutathione with charcoal, diatomaceous earth or other decolourising agents, f) spray-drying of the purified or partially purified glutathione solution
Impact of seminal trace element and glutathione (GSH) levels on semen quality of Tunisian infertile men
Track your food intake
Chest 135 , 344352 (2009)
